The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 11, 2017
Filed:
Dec. 16, 2015
Applicant:
Hoffmann-la Roche Inc., Little Falls, NJ (US);
Inventors:
Daniela Brunner, Riverdale, NY (US);
Hans Hilpert, Muenchenstein, CH;
Sabine Kolczewski, Loerrach, DE;
Anja Limberg, Basel, CH;
Jessica Malberg, Dobbs Ferry, NY (US);
Eric Prinssen, Guebwiller, FR;
Claus Riemer, Freiburg, DE;
Bavani G. Shankar, Nanuet, NY (US);
Theodor Stoll, Binningen, CH;
Assignee:
Hoffmann-La Roche Inc., Little Falls, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/404 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 403/14 (2006.01); A61K 31/4439 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 413/04 (2006.01); C07H 19/044 (2006.01); C07D 417/04 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); A61K 31/19 (2006.01); A61K 31/4178 (2006.01); A61K 31/422 (2006.01); A61K 31/4245 (2006.01); A61K 31/433 (2006.01); A61K 31/437 (2006.01); A61K 31/438 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 31/5383 (2006.01); A61K 31/55 (2006.01); A61K 31/7064 (2006.01); A61K 45/06 (2006.01); C07C 53/06 (2006.01); C07D 471/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 31/19 (2013.01); A61K 31/4178 (2013.01); A61K 31/422 (2013.01); A61K 31/4245 (2013.01); A61K 31/433 (2013.01); A61K 31/437 (2013.01); A61K 31/438 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/5383 (2013.01); A61K 31/55 (2013.01); A61K 31/7064 (2013.01); A61K 45/06 (2013.01); C07C 53/06 (2013.01); C07D 401/04 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 413/04 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 471/04 (2013.01); C07D 471/10 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01); C07H 19/044 (2013.01);
Abstract
The present invention is concerned with 2-oxo-2,3-dihydro-indoles of general formula (I) wherein Ar, X, X, R, R, R, m, n and the dotted line are as defined herein which compounds are useful for treating certain central nervous system disorders as described herein.